Advertisement
Person › Details
Georg Casari (Haplogen Bioscience GmbH)
Casari, Georg (CeMM 201211 Director + Haplogen 201211 CEO + founder before Oridis Biomed + Cellzome + Lion Bioscience)
Organisation | Haplogen Bioscience GmbH | |
Former/major organisation | Oridis Biomed Forschungs- und Entwicklungs GmbH | |
Today | Oridis Biomarkers GmbH | |
Group | Oridis Biomarkers GmbH | |
Product | anti-infective drug | |
Product 2 | virostatic agent | |
Record changed: 2020-12-14 |
Advertisement
More documents for Georg Casari
- [1] Biotech Austria. (12/10/20). "Press Release: Austria’s Biotechnology Companies Establish Biotech Austria – Biotech Industry Association". Vienna....
- [2] Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna....
- [3] Haplogen GmbH. (8/14/18). "Press Release: Haplogen Enters into a Collaboration with Bayer". Vienna....
- [4] Evotec AG. (8/14/18). "Press Release: Evotec Partner Haplogen Enters into Collaboration with Bayer". Hamburg....
- [5] Evotec AG. (1/12/17). "Press Release: Haplogen’s Novel Antiviral Target Partnered with Evotec Published in »Nature«". Vienna, Amsterdam & Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top